GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party
- 6 October 2026
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- p. 1-10
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxisAnnals of Hematology, 2025
- Post-transplant cyclophosphamide versus anti-thymocyte globulin in haploidentical stem cell transplantation: a systematic review and meta-analysisAnnals of Hematology, 2025
- Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working PartyCancer, 2024
- HCT in Elderly Patients2024
- The aging of the immune system and its implications for transplantationGeroScience, 2023
- Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationCancer, 2020
- Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantationAnnals of Hematology, 2020
- Relationship between Aging and Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2018
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumTransplantation and Cellular Therapy, 2016
- Chronic graft-versus-host syndrome in manThe American Journal of Medicine, 1980